Navigation Links
Society for Immunotherapy of Cancer (SITC) Congratulates 2018 Nobel Laureates, Past SITC Smalley Award Recipients, James P. Allison, PhD, and Tasuku Honjo, MD, PhD
Date:10/1/2018

The Society for Immunotherapy of Cancer (SITC) congratulates James P. Allison, PhD, and Tasuku Honjo, MD, PhD, renowned cancer immunotherapy scientists and past recipients of the society’s highest honor, for their reception of the Nobel Prize in the category of physiology or medicine.

Dr. Allison, Chair of the Department of Immunology at the University of Texas MD Anderson Cancer Center in Houston, and a SITC member since 2001, along with Prof. Honjo, Professor at the Department of Immunology and Genomic Medicine at Kyoto University in Japan, were awarded the Nobel Prize, “for their discovery of cancer therapy by inhibition of negative immune regulation,” the prize’s committee announced on Monday. Dr. Allison and Prof. Honjo are both past recipients of the SITC Richard V. Smalley, MD, Memorial Award and Lectureship, in 2010 and 2015, respectively. The SITC Smalley Award is the society’s highest honor recognizing a clinician/scientist who has contributed significantly to the advancement of cancer immunotherapy research.

Dr. Allison and Prof. Honjo helped pioneer the emerging field of immune checkpoint blockade therapy, which has become a foundational component of cancer treatment across the globe.

Research efforts lead by Dr. Allison helped define the role of CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) in immune system inhibition, and discovered that treatment of mice with an anti-CTLA-4 monoclonal antibody increased immune system elimination of cancer cells. These data ultimately contributed to the development of anti-CTLA-4 ipilimumab, which in 2011 became the first immune checkpoint inhibitor to gain approval by the U.S. Food and Drug Administration to treat cancer patients.

“Dr. Allison’s contributions towards the discovery and clinical development of immune checkpoint inhibitors have had an incalculable impact on cancer immunotherapy research and clinical translation,” said SITC President Lisa H. Butterfield, PhD. “Immunotherapy approaches to treat cancer may have existed for more than 100 years, but it was Dr. Allison’s breakthroughs in the lab which shed new light on these regulatory circuits that then enabled the revolution we now have in the field for patients. I am delighted to celebrate Dr. Allison’s newfound status as a Nobel Laureate.”

Research lead by Prof. Honjo helped identify PD-1 (Programmed cell death protein-1) as an integral component of immune system inhibition, noting that disruption of PD-1 in pre-clinical models resulted in increased immune system activity. This integral information helped initiate the development of anti-PD-1/PD-L1 (Programed death ligand-1) checkpoint inhibitors that are now widely used for the treatment of patients with cancer.

“The importance of the PD-1/PD-L1 pathway as a target for cancer treatment was a major advance made by Professor Honjo,” said SITC Immediate Past President Howard L. Kaufman. “His work identified a single immune pathway as critical to treating many different types of cancer, a finding that has established tumor immunotherapy as a valid approach for the treatment of cancer.”

While a SITC member for 17 years, Dr. Allison also served on the SITC Board of Directors from 2000-2001, co-chaired the society’s 2009 Annual Meeting, and has served as faculty, speaker and organizer of numerous other SITC meetings through the years.

“Dr. Allison’s insights have led to the development of life saving therapies for many patients,” said Patrick Hwu, MD, Head of the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. “In my own melanoma practice, I have numerous patients who previously would have had very poor prognoses, but are now living disease free for years due to these advances.”

A harmonica player, Dr. Allison is also a member of The CheckPoints, SITC’s house band featuring other luminaries in cancer immunotherapy research. Dr. Allison and The CheckPoints perform several times a year in support of the SITC Forward Fund, which provides grants and other research opportunities for early career scientists in the field of cancer immunotherapy. The CheckPoints will take the stage again on Saturday, Nov. 10, 2018 during the SITC 33rd Annual Meeting.

“These are incredibly important agents that have changed the way we treat cancer. They’ve benefited an enormous number of patients since their introduction into clinical trials, and have opened the field, creating excitement and increasing investment in research, which will lead to even greater treatment advances,” said SITC Vice President Mario Sznol, MD. “I congratulate Dr. Allison and Professor Honjo for their achievements, and also recognize the many others in the cancer research community who have played important roles in defining the biology of these pathways and bringing these agents into the clinic for our patients.”

Drs. Allison and Honjo are now the second and third SITC Smalley Award recipients to become Nobel Laureates. Ralph M. Steinman, MD, a 2011 recipient of the Smalley Award, was posthumously awarded the Nobel Prize in 2011 in the physiology or medicine category for his discovery of the dendritic cell and its role in adaptive immunity. To learn more about Dr. Allison and view several of his presentations from SITC meetings, visit SITC Cancer Immunotherapy CONNECT, the society’s official website.

About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

Read the full story at https://www.prweb.com/releases/society_for_immunotherapy_of_cancer_sitc_congratulates_2018_nobel_laureates_past_sitc_smalley_award_recipients_james_p_allison_phd_and_tasuku_honjo_md_phd/prweb15805103.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine news :

1. The Optical Society Presents Awards to Winners of Its Inaugural ‘Enabled by Optics’
2. Promoting chemistry through cooking: American Chemical Society Prized Science video
3. YourMembership.com’s JP Guilbault to Speak at New England Society of Association Executives 2013 Technology Conference
4. Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
5. Cataract surgery saves $123.4 billion in direct, indirect costs, delivers a 4,567 percent return to society
6. National MS Society partners with Accelerated Cure Project Online Forum to drive progress
7. GUMBOS promise new drugs and electronics: American Chemical Society Prized Science video
8. New Survey By The Secret Society of Happy People Proves Shopping Doesn't Equal A Happy Thanksgiving
9. GroupLink Battles IT Klingons & Cancer by Partnering with the American Cancer Society with No-Shave November & Attends HECC and CETPA Conferences
10. The International Society of Safety Professionals (ISSP) Announces "Career Track" a Development Framework for Safety Professionals
11. Nora Ross Donates Jojoba Oil to National MS Society Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2019)... ... May 23, 2019 , ... Smashtech has been named one of ... third year in a row. , Hitting newsstands May 28, in the June ... result of a wide-ranging and comprehensive measurement of private American companies that have created ...
(Date:5/23/2019)... ... May 23, 2019 , ... Mirror Mirror Beauty Boutique is happy to share ... of dedication to patient satisfaction and top-notch medical care. The 100th Google review ... patients can come for exceptional skincare and innovative, noninvasive techniques. , Google reviews ...
(Date:5/23/2019)... ... May 23, 2019 , ... In a ... Altus Assessments has published new research in an academic journal, Academic Medicine, demonstrating ... of increasing the racial and ethnic diversity of incoming medical students. , Although ...
(Date:5/23/2019)... ... May 23, 2019 , ... Hoban Law Group is proud to ... Legal Campaign. “It is essential to help educate the public about the most sweeping ... better place to do so than Times Square,” said Hoban Law Group Founder & ...
(Date:5/23/2019)... ... May 23, 2019 , ... Medicaid helps ... mothers, according to a new report by the Georgetown University Center for Children ... uninsured rates for women of childbearing age and larger reductions in maternal deaths ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... ... , ... Greenlight Guru, the only medical device quality ... Roadshow, a seven-city, countrywide gathering of medical device professionals and industry stakeholders, to ... The True Quality Roadshow will comprise of a networking event and ...
(Date:5/23/2019)... ... May 23, 2019 , ... PROSHRED® Seattle will be hosting ... in partnership with The American Institute for Cancer Research (AICR). Local residents are invited ... The event will be held at PROSHRED® Seattle’s location - 830 Industry Drive, Building ...
(Date:5/22/2019)... ... 2019 , ... A leading global health expert urged new Western University of ... health care successes and builds on them to make better lives for all the ... health at the University of Washington and Institute Director of the Institute for Health ...
Breaking Medicine Technology: